Christensen et al. 2013. Predicting transition temperature of elastin-like polypeptide fusion proteins. Biomacromolecules.

Christiansen et al. 2012. Weekly Subcutaneous Doses of (PB1023) a Novel GLP-1 Analogue Reduce Glucose Exposure Dose Dependently. Poster presentation at American Diabetes Association Annual Meeting 2012.

Kowalczyk et al. 2014. Elastin-like polypeptides as a promising family of genetically-engineered protein based polymers. World Journal of Microbiology and Biotechnology.

Luginbuhl et al. 2017.  One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer.  Nature Biomedical Engineering 1, Article number: 0078. doi:10.1038/s41551-017-0078.

Matson et al. 2011. (PB1023) a Novel GLP-1 Analogue Dose Dependently Reduces Meal Challenge Induced Glucose Exposure Following a Single Subcutaneous Dose. Poster presentation at the Annual Diabetes Technology Meeting 2011.

McDaniel et al. 2013. A unified model for de novo design of elastin-like polypeptides with tunable inverse transition temperatures. Biomacromolecules.